Akanda Corp. (AKAN)
USD 1.14
(3.64%)
USD 1.14
(3.64%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 2.49 Million USD | -9.16% |
| 2022 | 2.74 Million USD | 38.9% |
| 2021 | 1.97 Million USD | -69.9% |
| 2020 | 6.57 Million USD | 0.0% |
| 2019 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | - USD | 0.0% |
| 2023 Q2 | 2.48 Million USD | 0.0% |
| 2023 FY | 2.49 Million USD | -9.16% |
| 2023 Q3 | 2.49 Million USD | 0.59% |
| 2023 Q1 | 2.48 Million USD | -9.69% |
| 2023 Q4 | 2.49 Million USD | 0.0% |
| 2022 Q3 | 2.74 Million USD | 6.95% |
| 2022 Q2 | 2.57 Million USD | 0.0% |
| 2022 Q1 | 2.57 Million USD | 29.87% |
| 2022 FY | 2.74 Million USD | 38.9% |
| 2022 Q4 | 2.74 Million USD | 0.0% |
| 2021 FY | 1.97 Million USD | -69.9% |
| 2021 Q1 | - USD | -100.0% |
| 2021 Q4 | 1.97 Million USD | -41.89% |
| 2021 Q3 | 3.4 Million USD | 0.0% |
| 2020 Q4 | 6.57 Million USD | 0.0% |
| 2020 FY | 6.57 Million USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Bright Green Corporation | 201.78 Thousand USD | -1137.545% |
| Aquestive Therapeutics, Inc. | 91.07 Million USD | 97.258% |
| Journey Medical Corporation | 14.62 Million USD | 82.922% |
| Embecta Corp. | 1.62 Billion USD | 99.846% |
| Esperion Therapeutics, Inc. | 501.54 Million USD | 99.502% |
| Pacira BioSciences, Inc. | 513.79 Million USD | 99.514% |
| Sunshine Biopharma, Inc. | 539.03 Thousand USD | -363.264% |
| Alpha Teknova, Inc. | 13.25 Million USD | 81.155% |
| ANI Pharmaceuticals, Inc. | 309.66 Million USD | 99.194% |
| Collegium Pharmaceutical, Inc. | 489.96 Million USD | 99.49% |
| Cosmos Health Inc. | 3.03 Million USD | 17.731% |
| Dynavax Technologies Corporation | 252.41 Million USD | 99.011% |
| Intra-Cellular Therapies, Inc. | 13.32 Million USD | 81.261% |
| PainReform Ltd. | 30 Thousand USD | -8223.85% |
| Sunshine Biopharma, Inc. | 539.03 Thousand USD | -363.264% |
| SCYNEXIS, Inc. | 12.15 Million USD | 79.462% |
| Safety Shot Inc | 304.9 Thousand USD | -718.989% |
| China SXT Pharmaceuticals, Inc. | 117.12 Thousand USD | -2031.97% |
| Procaps Group, S.A. | 28.41 Million USD | 91.21% |
| Theratechnologies Inc. | 51.26 Million USD | 95.129% |
| Harrow Health, Inc. | 183.17 Million USD | 98.637% |
| Sonoma Pharmaceuticals, Inc. | 87 Thousand USD | -2770.293% |
| Biofrontera Inc. | 804 Thousand USD | -210.591% |
| DURECT Corporation | 2.7 Million USD | 7.581% |
| Supernus Pharmaceuticals, Inc. | 33.19 Million USD | 92.478% |
| Cronos Group Inc. | 1.55 Million USD | -60.177% |
| OptiNose, Inc. | 611 Thousand USD | -308.7% |
| Ironwood Pharmaceuticals, Inc. | 498.3 Million USD | 99.499% |
| Kala Pharmaceuticals, Inc. | 34.19 Million USD | 92.696% |
| RedHill Biopharma Ltd. | 455 Thousand USD | -448.825% |
| Organogenesis Holdings Inc. | 60.74 Million USD | 95.889% |
| Guardion Health Sciences, Inc. | - USD | -Infinity% |
| Cumberland Pharmaceuticals Inc. | 12.78 Million USD | 80.467% |
| Radius Health, Inc. | 339.66 Million USD | 99.265% |
| Universe Pharmaceuticals INC | - USD | -Infinity% |
| ProPhase Labs, Inc. | 10.25 Million USD | 75.657% |
| Phibro Animal Health Corporation | 458.28 Million USD | 99.455% |
| Procaps Group S.A. | 28.41 Million USD | 91.21% |
| Alvotech | 1.02 Billion USD | 99.757% |
| TherapeuticsMD, Inc. | 6.53 Million USD | 61.77% |
| Viatris Inc. | 16.18 Billion USD | 99.985% |
| Rockwell Medical, Inc. | 8.29 Million USD | 69.888% |
| Aytu BioPharma, Inc. | 10.87 Million USD | 77.042% |
| SIGA Technologies, Inc. | 335.99 Thousand USD | -643.221% |
| Tilray Brands, Inc. | 287.93 Million USD | 99.133% |
| Lifecore Biomedical, Inc. | 120.51 Million USD | 97.928% |
| Shineco, Inc. | 10.01 Million USD | 75.072% |
| PetIQ, Inc. | 437.82 Million USD | 99.43% |
| Regencell Bioscience Holdings Limited | - USD | -Infinity% |
| Incannex Healthcare Limited | 210 Thousand USD | -1089.121% |
| Neurocrine Biosciences, Inc. | 258.3 Million USD | 99.033% |
| Alimera Sciences, Inc. | 64.48 Million USD | 96.128% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Assertio Holdings, Inc. | 38.51 Million USD | 93.516% |
| Shuttle Pharmaceuticals Holdings, Inc. | 135.08 Thousand USD | -1748.526% |
| Petros Pharmaceuticals, Inc. | 6.85 Million USD | 63.584% |
| Clever Leaves Holdings Inc. | 720 Thousand USD | -246.827% |
| Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -11006.365% |
| Avadel Pharmaceuticals plc | 32.75 Million USD | 92.377% |
| Hempacco Co., Inc. | 5.93 Million USD | 57.897% |
| Talphera, Inc. | - USD | -Infinity% |
| Alvotech | 1.02 Billion USD | 99.757% |
| Eagle Pharmaceuticals, Inc. | 56.21 Million USD | 95.558% |
| Lantheus Holdings, Inc. | 616.12 Million USD | 99.595% |
| Currenc Group, Inc. | 2.5 Million USD | 0.392% |
| Kamada Ltd. | 7.43 Million USD | 66.427% |
| Indivior PLC | 235.66 Million USD | 98.94% |
| Evoke Pharma, Inc. | 5 Million USD | 50.057% |
| Flora Growth Corp. | 942 Thousand USD | -165.091% |
| Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -11006.365% |
| Evolus, Inc. | 120.35 Million USD | 97.925% |
| HUTCHMED (China) Limited | 48.18 Million USD | 94.818% |
| Amphastar Pharmaceuticals, Inc. | 589.19 Million USD | 99.576% |